Literature DB >> 10357465

High rate of human T lymphotropic virus type IIa infection in HIV type 1-infected intravenous drug abusers in Ireland.

J F Egan1, B O'Leary, M J Lewis, F Mulcahy, N Sheehy, H Hasegawa, F Fitzpatrick, J J O'Connor, J O'Riordan, W W Hall.   

Abstract

Serological and molecular analyses of a cohort of HIV-1-infected intravenous drug abusers (IVDAs) (n = 103) in Dublin, Ireland have demonstrated that 15 of 103 (14.6%) were infected with HTLV-II, which is the highest infection rate yet recorded for any European country. Restriction fragment length polymorphism (RFLP) analysis of the env region of the provirus demonstrated that the infection involved only the HTLV-IIa subtype; the HTLV-IIb subtype was not detected. Phylogenetic analysis of the nucleotide sequences of the long terminal repeat (LTR) confirmed infection with the HTLV-IIa subtype, and demonstrated that the viruses clustered closely with HTLV-IIa isolates from North American IVDAs. Previous observations that IVDAs in southern Europe, specifically Spain and Italy, appear to be infected predominantly with the HTLV-IIb subtype, along with the present report and evidence that IVDAs in Sweden are infected with the HTLV-IIa subtype, suggest different origins of HTLV-II infection in Europe.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357465     DOI: 10.1089/088922299310782

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  Upregulation of HTLV-1 and HTLV-2 expression by HIV-1 in vitro.

Authors:  Upal Roy; Scott A Simpson; Debasis Mondal; Sandra Eloby-Childress; Elsa L Winsor; Mark A Beilke
Journal:  J Med Virol       Date:  2008-03       Impact factor: 2.327

2.  Human T cell lymphotropic virus type 2a strains among HIV type 1-coinfected patients from Brazil have originated mostly from Brazilian Amerindians.

Authors:  Mariana Cavalheiro Magri; Luis Fernando de Macedo Brigido; Helena Kaminami Morimoto; Adele Caterino-de-Araujo
Journal:  AIDS Res Hum Retroviruses       Date:  2013-04-11       Impact factor: 2.205

3.  Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.

Authors:  Ene-Ly Jõgeda; Radko Avi; Merit Pauskar; Eveli Kallas; Tõnis Karki; Don Des Jarlais; Anneli Uusküla; Irja Lutsar; Kristi Huik
Journal:  Infect Genet Evol       Date:  2016-05-17       Impact factor: 3.342

4.  A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling.

Authors:  Ruth Zimmermann; Ulrich Marcus; Dirk Schäffer; Astrid Leicht; Benjamin Wenz; Stine Nielsen; Claudia Santos-Hövener; R Stefan Ross; Oumaima Stambouli; Boris-Alexander Ratsch; Norbert Bannert; Claus-Thomas Bock; Claudia Kücherer; Osamah Hamouda
Journal:  BMC Public Health       Date:  2014-08-14       Impact factor: 3.295

5.  No significant HTLV seroprevalence in German people who inject drugs.

Authors:  Oliver Hohn; Stephen Norley; Claudia Kücherer; Ali Bazarbachi; Hiba El Hajj; Ulrich Marcus; Ruth Zimmermann; Norbert Bannert
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

6.  Molecular detection of human T-lymphotropic virus type 1 infection among oncology patients in Germany: A retrospective view.

Authors:  Matias Ruggieri; Carolina Berini; Nicolas Ducasa; Miroslav Malkovsky; Paul Fisch; Mirna Biglione
Journal:  PLoS One       Date:  2019-05-28       Impact factor: 3.240

Review 7.  The challenge of describing the epidemiology of HTLV in the Amazon region of Brazil.

Authors:  Ricardo Ishak; Marluísa de Oliveira Guimarães Ishak; Antonio Carlos R Vallinoto
Journal:  Retrovirology       Date:  2020-02-14       Impact factor: 4.602

8.  Human T-lymphotropic virus in Irish blood donors: Impact on future testing strategy.

Authors:  Pádraig Williams; Niamh O'Flaherty; Stephen Field; Allison Waters
Journal:  Transfusion       Date:  2022-07-13       Impact factor: 3.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.